Clinical Trial Update: A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS) [Phase 3]

View source ↗

Summary

A Phase 3 pediatric study evaluating the safety of diroximel fumarate and dimethyl fumarate and their effect on relapses in relapsing forms of multiple sclerosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)
• Diroximel Fumarate (diroximel fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | Phase 3 | Status: NOT_YET_RECRUITING